SCHEDULE 2 CONTROLLED DRUGS SUBJECT TO THE REQUIREMENTS OF REGULATIONS 14, 15, 16, F1016A, 18, 19, 20, 21, 23, 26 AND 27
1
The following substances and products, namely—
Acetorphine
Alfentanil
Allylprodine
Alphacetylmethadol
Alphameprodine
Alphamethadol
Alphaprodine
F5Amineptine
Anileridine
Benzethidine
Benzylmorphine (3-benzylmorphine)
Betacetylmethadol
Betameprodine
Betamethadol
Betaprodine
Bezitramide
F12Cannabis-based product for medicinal use in humans
Carfentanil
Clonitazene
Cocaine
Desomorphine
Dextromoramide
Diamorphine
Diampromide
Diethylthiambutene
Difenoxin
Dihydrocodeinone O-carboxymethyloxime
F1Dihydroetorphine
Dihydromorphine
Dimenoxadole
Dimepheptanol
Dimethylthiambutene
Dioxaphetyl butyrate
Diphenoxylate
Dipipanone
Dronabinol
Drotebanol
Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine
Ethylmethylthiambutene
Etonitazene
Etorphine
Etoxeridine
Fentanyl
Furethidine
Hydrocodone
Hydromorphinol
Hydromorphone
F84-Hydroxy-n-butyric acid
Hydroxypethidine
Isomethadone
F9Ketamine
Ketobemidone
Levomethorphan
Levomoramide
Levophenacylmorphan
Levorphanol
F7Lisdexamphetamine
Lofentanil
Medicinal opium
Metazocine
Methadone
Methadyl acetate
Methyldesorphine
Methyldihydromorphine (6-methyldihydromorphine)
Metopon
Morpheridine
Morphine
Morphine methobromide, morphine N-oxide and other pentavalent nitrogen morphine derivatives
Myrophine
F3Nabilone
Nicomorphine
Noracymethadol
Norlevorphanol
Normethadone
Normorphine
Norpipanone
F4Oripavine
Oxycodone
Oxymorphone
Pethidine
Phenadoxone
Phenampromide
Phenazocine
Phencyclidine
Phenomorphan
Phenoperidine
Piminodine
Piritramide
Proheptazine
Properidine
Racemethorphan
Racemoramide
Racemorphan
F2Remifentanil
Sufentanil
F6Tapentadol
Thebacon
Thebaine
Tilidate
Trimeperidine
Zipeprol
4-Cyano-2-dimethylamino-4,4-diphenylbutane
4-Cyano-1-methyl-4-phenylpiperidine
2-Methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid
a-Methylphenethylhydroxylamine
1-Methyl-4-phenylpiperidine-4-carboxylic acid
4-Phenylpiperidine-4-carboxylic acid ethyl ester
2
Any stereoisomeric form of a substance specified in paragraph 1 not being dextromethorphan or dextrorphan.
3
Any ester or ether of a substance specified in paragraph 1 or 2, not being a substance specified in paragraph 6.
4
Any salt of a substance specified in any of paragraphs 1 to 3.
5
Any preparation or other product containing a substance or product specified in any of paragraphs 1 to 4, not being a preparation specified in Schedule 5.
F115A
But paragraphs 2 to 5 only apply in respect of a cannabis-based product for medicinal use in humans if the cannabis-based product that would, as a consequence of paragraphs 2 to 5, be specified in this Schedule but for the operation of this paragraph, is produced for medicinal use in humans.
6
The following substances and products, namely—
Acetyldihydrocodeine | Methaqualone |
Amphetamine | Methylamphetamine |
Codeine | Methylphenidate |
Dextropropoxyphene | Nicocodine |
Dihydrocodeine | Nicodicodine (6-nicotinoyldihydrocodeine) |
Ethylmorphine (3-ethylmorphine) | Norcodeine |
Fenethylline | Phenmetrazine |
Glutethimide | Pholcodine |
Lefetamine | Propiram |
Mecloqualone | Quinalbarbitone |
7
Any stereoisomeric form of a substance specified in paragraph 6.
8
Any salt of a substance specified in paragraph 6 or 7.
9
Any preparation or other product containing a substance or product specified in any of paragraphs 6 to 8, not being a preparation specified in Schedule 5.
Word in Sch. 2 heading inserted (1.11.2018) by The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018 (S.I. 2018/1055), regs. 1(1), 7(a)